This article provides a comprehensive analysis for researchers and drug development professionals on the critical challenge of tumor heterogeneity in targeted cancer therapy.
Cancer stem cells (CSCs) are a therapy-resistant subpopulation that drive tumor initiation, progression, metastasis, and relapse.
This article provides a comprehensive overview of the current landscape of Chimeric Antigen Receptor (CAR)-T cell engineering and manufacturing.
This article provides a comprehensive overview of liquid biopsy technologies for cancer monitoring, tailored for researchers, scientists, and drug development professionals.
Spatial transcriptomics (ST) has emerged as a transformative technology that preserves the spatial context of gene expression within intact tissues, providing unprecedented insights into the complex architecture of the tumor...
This article provides a comprehensive overview of the transformative role of CRISPR-Cas9 technology in cancer research and therapy.
Single-cell sequencing technologies have revolutionized our understanding of tumor heterogeneity, providing unprecedented resolution to analyze genomic, transcriptomic, and epigenomic variations within individual cancer cells.
This article provides a comprehensive comparison of Digital PCR (dPCR) and Real-Time PCR (qPCR) for the detection and analysis of circulating tumor DNA (ctDNA), a critical biomarker in liquid biopsies.
This article provides a comprehensive analysis of machine learning (ML) applications in cancer detection using genomic data, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive examination of next-generation sequencing (NGS) protocols and their transformative impact on cancer genomics.